Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Редкие коагулопатии: наследственный дефицит факторов свертывания крови II, VII, X

Список литературы

  1. Воробьев АИ, editor. Руководство по гематологии: в 3 т. М.: “Ниюдиамед”; 2005.
  2. Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: Results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012;10:615–21. https://doi.org/10.1111/j.1538-7836.2012.04653.x.
  3. Acharya SS, Coughlin A, Dimichele DM, Jublirer SJ, Arden D, Anderson V, et al. Rare bleeding disorder registry: Deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004;2:248–56. https://doi.org/10.1111/j.1538-7836.2003.t01-1-00553.x.
  4. Herrmann FH, Auerswald G, Ruiz-Saez A, Navarrete M, Pollmann H, Lopaciuk S, et al. Factor X deficiency: Clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia 2006;12:479–89. https://doi.org/10.1111/j.1365-2516.2006.01303.x.
  5. Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, et al. Factor VII deficiency: Clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009;15:267–80. https://doi.org/10.1111/j.1365-2516.2008.01910.x.
  6. Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RAS, et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007;97:914–21.
  7. BERNARDI F, DOLCE A, PINOTTI M, SHAPIRO AD, SANTAGOSTINO E, PEYVANDI F, et al. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B. J Thromb Haemost 2009;7:774–9. https://doi.org/10.1111/j.1538-7836.2009.03329.x.
  8. Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al. Guideline for the diagnosis and management of the rare coagulation disorders: A United Kingdom haemophilia centre doctors’ organization guideline on behalf of the British committee for standards in haematology. Br J Haematol 2014;167:304–26.
  9. Peyvandi F, Di Michele D, Bolton-Maggs PHB, Lee CA, Tripodi A, Srivastava A. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012;10:1938–43. https://doi.org/10.1111/j.1538-7836.2012.04844.x.
  10. Баркаган ЗС, Момот АП. Диагностика и контролируемая терапия нарушений гемостаза. 2001.
  11. Давыдкин ИЛ, Момот АП, Зозуля НИ, Ройтман ЕВ, editors. Основы клинической гемостазиологии и гемореологии: монография. Самара: ООО ИПК «Самарская Губерния»; 2017.
  12. Akhavan S, Mannucci PM, Lak M, Mancuso G, Mazzucconi MG, Rocino A, et al. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost 2000;84:989–97. https://doi.org/10.1055/s-0037-1614161.
  13. Bolton-Maggs PHB, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disorders - Review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 2004;10:593–628. https://doi.org/10.1111/j.1365-2516.2004.00944.x.
  14. GIROLAMI A, VETTORE S, SCARPARO P, LOMBARDI AM. Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era. Haemophilia 2011;17:17–20. https://doi.org/10.1111/j.1365-2516.2010.02328.x.
  15. KARIMI M, VAFAFAR A, HAGHPANAH S, PAYANDEH M, ESHGHI P, HOOFAR H, et al. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. Haemophilia 2012;18:211–5. https://doi.org/10.1111/j.1365-2516.2011.02635.x.
  16. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005;93:481–7. https://doi.org/10.1160/TH04-10-0650.
  17. Момот АП. Принципы и алгоритмы клинико-лабораторной диагностики. СПб: ФормаТ; 2006.
  18. Добровольский АБ, Косырев АБ. Протромбиновый тест: Методика выполнения и клиническое значение. Ассоциация Медицинской Лабораторной Диагностики Информационный Бюллетень 1995;2:34–8.
  19. BROWN DL, KOUIDES PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008;14:1176–82. https://doi.org/10.1111/j.1365-2516.2008.01856.x.
  20. Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: An update. Semin Thromb Hemost 2013;39:596–606. https://doi.org/10.1055/s-0033-1348948.
  21. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243–52. https://doi.org/10.1182/blood-2004-02-0595.
  22. Di Minno MND, Dolce A, Mariani G. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb Haemost 2013;109:1051–9. https://doi.org/10.1160/TH12-10-0740.
  23. Giansily-Blaizot M, Marty S, Chen SWW, Pellequer JL, Schved JF. Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous? Thromb Res 2012;130. https://doi.org/10.1016/j.thromres.2012.08.273.
  24. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2008;14:671–84. https://doi.org/10.1111/j.1365-2516.2008.01695.x.
  25. Girolami A, Vettore S, Ruzzon E, Marinis GB De, Fabris F. Rare and unusual bleeding manifestations in congenital bleeding disorders: An annotated review. Clin Appl Thromb 2012;18:121–7. https://doi.org/10.1177/1076029611416638.
  26. Ушакова ОЕ, Нечипуренко ДЮ, Бутылин АА, Пантелеев МА. Применение проточных систем в лабораторной диагностике для интегральной оценки системы гемостаза. Вопросы Гематологии / Онкологии и Иммунопатологии в Педиатрии 2018;17:117–29.
  27. Franchini M, Lippi G. Prothrombin complex concentrates: An update. Blood Transfus 2010;8:149–54. https://doi.org/10.2450/2010.0149-09.
  28. Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood 2019;133:415–24. https://doi.org/10.1182/blood-2018-06-820738.
  29. Dorgalaleh A, Tabibian S, Hosseini MS, Shams M. Pharmacological management of rare coagulation factor deficiencies besides hemophilia. Expert Rev Hematol 2020;13. https://doi.org/10.1080/17474086.2020.1796622.
  30. Peyvandi F, Menegatti M. Treatment of rare factor deficiencies in 2016. Hematol Am Soc Hematol Educ Progr 2016;2016:663–9. https://doi.org/10.1182/ASHEDUCATION-2016.1.663.
  31. TODD T, J PERRY D. A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies. Haemophilia 2009;16:569–83. https://doi.org/10.1111/j.1365-2516.2009.02118.x.
  32. Tengborn L, Blombäck M, Berntorp E. Tranexamic acid - An old drug still going strong and making a revival. Thromb Res 2015;135:231–42. https://doi.org/10.1016/j.thromres.2014.11.012.
  33. Berrettini M, Mariani G, Schiavoni M, Rocino A, Paolantonio T Di, Longo G, et al. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency. vol. 86. 2001. https://doi.org/10.3324/%X.
  34. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: Therapy with recombinant activated factor VII - A critical appraisal. Haemophilia 2006;12:19–27. https://doi.org/10.1111/j.1365-2516.2006.01180.x.
  35. Mariani G, Dolce A, Batorova A, Auerswald G, Schved JF, Siragusa S, et al. Recombinant, activated factor VII for surgery in factor VII deficiency: A prospective evaluation - the surgical STER. Br J Haematol 2011;152:340–6. https://doi.org/10.1111/j.1365-2141.2010.08287.x.
  36. Mariani G, Napolitano M, Dolce A, Garrido RP, Batorova A, Karimi M, et al. Replacement therapy for bleeding episodes in factor VII deficiency. Thromb Haemost 2013;109:238–47. https://doi.org/10.1160/TH12-07-0476.
  37. Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, et al. Prophylaxis in congenital factor VII deficiency: Indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica 2013;98:538–44. https://doi.org/10.3324/haematol.2012.074039.
  38. Mariani G, Dolce A, Marchetti G, Bernardi F. Clinical picture and management of congenital factor VII deficiency. Haemophilia 2004;10 Suppl 4:180–3. https://doi.org/10.1111/J.1365-2516.2004.00990.X.
  39. Salcioglu Z, Akcay A, Sen HS, Aydogan G, Akici F, Tugcu D, et al. Factor VII deficiency: a single-center experience. Clin Appl Thromb Hemost 2012;18:588–93. https://doi.org/10.1177/1076029611435091.
  40. McMahon C, Smith J, Goonan C, Byrne M, Smith OP. The role of primary prophylactic factor replacement therapy in children with severe factor X deficiency. Br J Haematol 2002;119:789–91. https://doi.org/10.1046/j.1365-2141.2002.03932.x.
  41. Суворова АВ, Абраменко ЛИ, Курденко ИВ, Назарова РВ. Патология системы гемостаза у новорожденных. Барнаул: 2004.
  42. Шабалов НП. Гемостаз в динамике первой недели жизни как отражение механизмов адаптации к внеутробной жизни новорожденных. Педиатрия 2000;3:84–91.
  43. BOWLES L, BAKER K, KHAIR K, MATHIAS M, LIESNER R. Prophylaxis with prothrombin complex concentrate in four children with severe congenital factor X deficiency. Haemophilia 2009;15:401–3. https://doi.org/10.1111/j.1365-2516.2008.01878.x.
  44. Barillari G, Pasca S, Gonano N, Daminato R. Prothrombin complex concentrate such as therapy and prophylaxis in factor X-deficient patient (Friuli Variant). Clin Appl Thromb 2011;17:332–6. https://doi.org/10.1177/1076029610365331.
  45. Kouides PA, Kulzer L. Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate. Haemophilia 2001;7:220–3. https://doi.org/10.1046/j.1365-2516.2001.00485.x.
  46. Uprichard J, Perry DJ. Factor X deficiency. Blood Rev 2002;16:97–110. https://doi.org/10.1054/blre.2002.0191.
  47. Van Veen JJ, Hampton KK, Maclean R, Fairlie F, Makris M. Blood product support for delivery in severe factor X deficiency: The use of thrombin generation to guide therapy. Blood Transfus 2007;5:204–9. https://doi.org/10.2450/2007.0023-07.
  48. Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, et al. Correlating clinical manifestations with factor levels in rare bleeding disorders: A report from Southern India. Haemophilia 2012;18. https://doi.org/10.1111/j.1365-2516.2011.02730.x.
  49. KADIR R, CHI C, BOLTON-MAGGS P. Pregnancy and rare bleeding disorders. Haemophilia 2009;15:990–1005. https://doi.org/10.1111/j.1365-2516.2009.01984.x.
  50. Baumann Kreuziger LM, Morton CT, Reding MT. Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia 2013;19:827–32. https://doi.org/10.1111/hae.12167.
  51. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006;12:413–6. https://doi.org/10.1111/j.1365-2516.2006.01287.x.
  52. Beksaç MS, Atak Z, Özlü T. Severe factor X deficiency in a twin pregnancy. Arch Gynecol Obstet 2010;281:151–2. https://doi.org/10.1007/s00404-009-1090-4.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*